Buy Ranbaxy Laboratories: Sukhani

54182 Investors following Ranbaxy Labs. Share this News with them.

0

Like this story, share it with millions of investors on M3

Buy Ranbaxy Laboratories: Sukhani

Buy Ranbaxy Laboratories, says Technical Analyst, Sudarshan Sukhani.

Post your opinion here

 

0

Tweet

Share on Tumblr

Excerpts from Bazaar on CNBC-TV18 Watch the full show » ALSO READ See previous views by Sudarshan Sukhani See what other Experts & Brokerages are saying about Ranbaxy Labs See messages about Ranbaxy Labs Ranbaxy Labs BSE | NSE 10/02/12 Are Mutual Funds betting on Ranbaxy Labs?

Buy Ranbaxy Laboratories , says Technical Analyst, Sudarshan Sukhani .

Sukhani told CNBC-TV18, "Ranbaxy Laboratories has been in a roll after that big decline. It has rallied significantly from more than Rs 250. Yesterday it built on some gains even though the markets are flat; I think that should continue today. The stock has broken out decisively over Rs 400 range. So Ranbaxy is a buying opportunity."

He further added, "One should keep a stoploss at Rs 410 but for a positional short-term swing trader, you can look at Rs 460. For somebody who is trading for a day take whatever gains come but one can actually hold the stock."